UCLA receives nearly $14 million from NIH to investigate gene therapy to combat HIV
University of California, Los Angeles (UCLA), Health SciencesUCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.